StonvexLoading…
StonvexStonvexStonvexCore line items from GLW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.63B | $13.12B | $12.59B | $14.19B |
Operating Income | $2.28B | $1.14B | $890.00M | $1.44B |
Net Income | $1.60B | $506.00M | $581.00M | $1.32B |
EPS (Diluted) | $1.83 | $0.58 | $0.68 | $1.54 |
Total Assets | $30.98B | $27.73B | $28.50B | $29.50B |
Total Liabilities | $18.67B | $16.66B | $16.63B | $17.22B |
Cash & Equivalents | $1.53B | $1.77B | $1.78B | $1.67B |
Free Cash Flow OCF − CapEx | $1.41B | $974.00M | $615.00M | $1.01B |
Shares Outstanding | 871.00M | 869.00M | 859.00M | 857.00M |